Penumbra
PEN
#1783
Rank
NZ$15.74 B
Marketcap
$410.30
Share price
0.54%
Change (1 day)
7.89%
Change (1 year)
Categories
Penumbra, Inc., is an American company that develops, manufactures and sells medical devices for neurovascular and vascular medicine applications.

Penumbra (PEN) - Total assets

Total assets on the balance sheet as of September 2024 : NZ$2.52 Billion

According to Penumbra's latest financial reports the company's total assets are NZ$2.52 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Penumbra - Total assets on balance sheet (from 2014 to 2024)

Total assets by year

Year Total assets Change
2023-12-31NZ$2.46 B13.97%
2022-12-31NZ$2.15 B18.53%
2021-12-31NZ$1.82 B59.71%
2020-12-31NZ$1.14 B15.36%
2019-12-31NZ$0.98 B28.78%
2018-12-31NZ$0.76 B14.39%
2017-12-31NZ$0.67 B50.82%
2016-12-31NZ$0.44 B15.43%
2015-12-31NZ$0.38 B148.85%
2014-12-31NZ$0.15 B78.93%
2013-12-31NZ$86.57 M

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
NZ$1.18 B-52.86%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$4.05 B 60.78%๐Ÿ‡บ๐Ÿ‡ธ USA